Open any social feed and you can find someone strapping a glowing red panel to their face or lying inside a softly lit blanket. Captions promise softer skin, thicker hair, faster recovery, calmer moods, sometimes even fat loss. Marketplaces are full of masks, mats, helmets and belts, advertised for use at home without any clinician involvement.

It is tempting to file the category under "wellness theatre." But underneath the marketing sits a real, decades-old field of research called photobiomodulation, with serious clinical trials and some treatments now recommended in oncology guidelines.

The problem is that the gap between what photobiomodulation can plausibly do and what at-home devices are sold for has become enormous. This article walks through what red light therapy actually is, where the evidence is solid, where it is thin or absent, and how to think about safety before you spend several hundred dollars on a glowing panel.

What red light therapy actually is

"Red light therapy" is the consumer label for what scientists call photobiomodulation (PBM), sometimes still referred to as low-level laser therapy or low-level light therapy. The basic idea is simple: shine light of specific wavelengths on tissue at doses too low to cause heating, and look for biological changes.

The wavelengths matter. Visible red light sits roughly between 630 and 700 nanometres, while near-infrared light covers about 700 to 1100 nanometres. Most clinical photobiomodulation studies use wavelengths in the 600–1100 nm range, with red light penetrating a few millimetres into skin and near-infrared reaching deeper tissues such as muscle and joints.

The leading mechanistic explanation involves the mitochondria — the energy-producing organelles in your cells. According to a widely cited 2018 review by photomedicine researcher Michael Hamblin, red and near-infrared photons are absorbed by an enzyme in the mitochondrial respiratory chain called cytochrome c oxidase. The favoured hypothesis is that this absorption dissociates inhibitory nitric oxide from the enzyme, restoring electron transport, nudging up ATP production, and triggering a cascade of redox-signalling changes that affect inflammation, gene expression and tissue repair.

That sentence is doing a lot of work. The mitochondrial story is the most coherent we have, but the field admits we do not fully understand how photobiomodulation produces its clinical effects in any specific condition.

Skin: the strongest consumer-facing evidence

The most studied cosmetic application is facial skin rejuvenation. Several randomised trials have measured wrinkles, skin roughness and collagen density before and after weeks of red and near-infrared light exposure.

A frequently cited controlled trial in Photomedicine and Laser Surgery randomised participants to red and near-infrared light treatment or no treatment over 30 sessions. The treatment group showed significant improvements in skin complexion, fine lines, wrinkles and intradermal collagen density on ultrasound, with most participants rating their appearance as noticeably improved. Effects were modest in absolute terms but consistent across measures.

More recent work has extended this to home-use devices. A 2025 multi-centre, double-blind, sham-controlled trial of a home LED (light-emitting diode) mask delivering both red (around 630 nm) and near-infrared (around 830 nm) light found measurable improvements in crow's-feet wrinkling among adults aged 30 to 65 over an 8-week course. A broader 2025 review in Photodermatology, Photoimmunology and Photomedicine concluded that LED phototherapy has become a legitimate non-invasive option in cosmetic dermatology, while emphasising that effect sizes are smaller than those from prescription retinoids or in-office laser procedures.

The honest summary: red light therapy can produce a real but modest improvement in skin texture and fine lines. It is not a face-lift, does not replace sunscreen, and gains fade if you stop. Within those limits, this is the most robustly evidenced cosmetic claim the technology has.

Hair: a real but specific effect

The second-best-studied consumer application is androgenetic alopecia — the patterned hair thinning that affects a large fraction of men and women with age. Several Food and Drug Administration-cleared low-level laser therapy (LLLT) helmets, combs and caps are now on the market.

A meta-analysis published in Lasers in Medical Science pooled data from eleven double-blind randomised trials and found a statistically significant increase in hair density in participants treated with low-level laser therapy compared with sham devices, with benefits seen in both men and women and across helmet- and comb-type devices. A separate 2023 randomised controlled trial found measurable increases in hair density at six months in the laser-treated group versus controls. A 2022 systematic review of FDA-cleared home-use devices concluded that the technology is supported by reasonable trial-level evidence, though it is not a replacement for first-line drugs such as minoxidil or finasteride.

What does this look like in practice? Modest, additive benefits — a few percent more hairs per square centimetre, mild improvements in thickness — typically observed after months of consistent use. Side effects are usually limited to temporary scalp itch or shedding. If you have early-stage androgenetic alopecia, an FDA-cleared device used alongside (not instead of) standard treatments is a defensible add-on. If you are completely bald, no LED helmet will regrow follicles that no longer exist.

Wound healing, oncology side effects, and joint pain

Outside of cosmetic applications, photobiomodulation has its strongest medical foothold in supportive cancer care. International multidisciplinary guidelines now recommend photobiomodulation to prevent radiation-induced skin reactions in patients receiving radiotherapy for breast cancer. A separate Multinational Association of Supportive Care in Cancer review supports its use to prevent oral mucositis — painful inflammation of the mouth lining — in patients undergoing certain chemotherapy and radiotherapy regimens. These are not casual recommendations; they are made within formal oncology supportive-care guidelines.

For diabetic foot ulcers, the evidence is encouraging but messier. A 2023 systematic review found that photobiomodulation appears to improve wound closure rates and reduce inflammation in diabetic foot ulcers, but the authors flag wide variation in trial quality and treatment parameters. Photobiomodulation is best regarded as a promising adjunct to standard wound care, not a stand-alone therapy.

In joint pain, particularly knee osteoarthritis, a 2024 meta-analysis in Physical Therapy concluded that photobiomodulation can reduce pain and disability compared with sham, especially when combined with exercise. A network meta-analysis suggested that wavelengths in the 785–860 nm or 904 nm range produced the largest pain reductions. The certainty of evidence is rated low, so this is not a replacement for proven treatments — but it is a reasonable adjunct in physical therapy clinics that already use it.

For age-related macular degeneration, the FDA has now authorised photobiomodulation devices as part of treatment for early dry-form disease, although this is firmly in the territory of medical, clinician-supervised use, not at-home wellness.

Acne: yes, but mostly the blue half

LED therapy for acne usually combines blue light (around 415 nm) with red light (around 633 nm). Blue light targets the bacteria Cutibacterium acnes; red light is added for its anti-inflammatory effect.

A 2024 review of visible-light therapy for acne examined 35 studies and reported partial improvement in the majority of patients, with combination blue–red protocols generally outperforming single wavelengths. A randomised trial directly comparing red and blue light for mild-to-moderate acne found similar overall improvement, though red light caused fewer adverse reactions.

The practical implication: if you have mild-to-moderate inflammatory acne, an LED mask may help as a complement to a dermatologist-recommended routine. It will not replace topical retinoids, benzoyl peroxide or, where indicated, prescription medications. And anyone on systemic isotretinoin or other photosensitising medication should avoid LED therapy until cleared by their physician — these drugs render skin hyper-reactive to light, even at the long wavelengths used in LED devices.

Where the evidence is weak or absent

The marketing for red light therapy has wandered far beyond what the trials actually support. Three claims, in particular, deserve scrutiny.

Weight loss and "fat reduction." A handful of small industry-linked studies report modest changes in body circumference after laser-like devices, but there is no robust independent evidence that home red light panels meaningfully reduce body fat. The mechanism stories invoked here — supposed effects on adipocyte permeability — remain speculative.

"Detoxification." "Detox" is not a meaningful clinical concept outside of poisoning and drug overdose. No serious photobiomodulation researcher claims that red light therapy clears toxins from the body, because there is no defined toxin and no mechanism by which red light would accelerate any of the actual organs (liver, kidneys) that handle metabolic waste.

Mood, sleep and seasonal affective disorder. This is the most subtle case. Light therapy genuinely works for seasonal affective disorder — but the evidence-based protocol is bright white light, typically delivered at around 10,000 lux for 30 minutes in the morning, not red or near-infrared light. A systematic review and network meta-analysis of treatments for seasonal affective disorder found bright (mostly white) light therapy to be the most effective non-pharmacological intervention, with white light specifically outperforming red for typical depressive symptoms. Some early trials are exploring transcranial near-infrared photobiomodulation for depression, but this is a research frontier — not a justification for buying a red panel and pointing it at your forehead. If you have winter depression, bright light therapy is a different and better-supported treatment than red light.

A New York Times Magazine writer who tested a red-light blanket reported feeling more energetic, impulsive, and "a little angry" — but not relaxed. That is consistent with how the colour red is processed: it is associated with threat and prohibition in attention research, and prolonged red-lit environments may trigger arousal rather than calm. If you are trying to wind down before bed, an ambient red glow is not the same as evidence-based sleep hygiene.

Clinical devices versus the gadget you can buy online

A crucial point is often missed in consumer reviews: not all red light is created equal.

Clinical photobiomodulation studies use devices with carefully specified parameters — wavelength, irradiance (power per square centimetre), total fluence (energy delivered per area), session length, distance from the skin, and number of sessions. When researchers say "red light therapy works for X," they mean it works at those specific parameters, not for any glowing red panel.

Most at-home devices sold through marketplaces are not regulated as medical devices. As an investigation by NPR documented, home gadgets may emit wavelengths and intensities that differ substantially from those used in clinical trials. Some lack adequate near-infrared output. Others under-deliver irradiance, so the dose at the skin is far below trial protocols. Many make therapeutic claims they cannot legally support.

The FDA's role here is narrower than people assume. Many devices carry a "510(k) cleared" stamp, which means the manufacturer convinced regulators that the product is substantially equivalent in safety to an existing cleared device — typically with a specific allowed claim such as "temporary relief of minor muscle pain" or "treatment of wrinkles." It is not a guarantee of efficacy, nor does it mean the device matches the parameters used in published trials.

If you are evaluating a device, look for: a clearly stated wavelength (ideally listing both red and near-infrared peaks), a published irradiance figure (mW/cm² at a stated distance), an FDA-clearance number you can look up, and a generous return window. Be sceptical of any vendor that lists dozens of unrelated medical conditions on their landing page.

Safety: usually mild, but with real edge cases

For most healthy adults using consumer-grade devices, red light therapy is reasonably safe. The American Academy of Dermatology notes that adverse effects are typically limited to mild reactions — brief redness, warmth, itching, or a transient headache.

The most important short-term safety issue is your eyes. Bright LED panels are not the same as clinical lasers, but prolonged direct exposure can be problematic. A retrospective analysis in Ophthalmic and Physiological Optics describes cases of retinal damage linked to misused near-infrared and red devices. Follow the manufacturer's eye-protection guidance and do not stare into the panel.

Key contraindications:

  • Photosensitising medications. Isotretinoin, certain antibiotics (tetracyclines, fluoroquinolones), some antifungals and St John's wort can increase skin reactivity to light. Wait for clearance from your prescriber.
  • Light-sensitive conditions. People with lupus, porphyria or other photosensitivity disorders should not use red light therapy without medical advice.
  • Active or suspicious skin lesions. Do not shine red light directly on undiagnosed moles, suspected skin cancers or active infections.
  • Pregnancy. Trials excluded pregnant participants, so safety here is unknown rather than ruled out.
  • Darker skin tones. The American Academy of Dermatology notes that darker skin may be more reactive, with some risk of post-inflammatory hyperpigmentation.

There is also a longer-term gap: most trials follow participants for weeks to months, not years. "Safe in trials lasting 12 weeks" is not the same as "safe for life."

How to use red light therapy without getting fooled

If, after reading all of the above, you still want to try it, here is a sensible approach.

Start with a goal that has trial support. The strongest cases are facial skin texture and fine lines, androgenetic alopecia, and possibly mild-to-moderate acne. If your reason is something more diffuse — "better wellbeing," "more energy," "detox" — the literature does not have your back.

Match the device to the goal. A facial mask with red and near-infrared output is appropriate for skin. A low-level laser cap or comb specifically cleared for hair loss is appropriate for hair. A general-purpose panel marketed for everything is appropriate for nothing in particular.

Read the fine print on dose. Sessions in clinical trials are typically a few minutes per area, several times per week, for at least 8–12 weeks. "More" is not better — irradiance and dose matter, and very high doses can plateau or even reverse benefits.

Track your skin or scalp objectively. Red light therapy effects are subtle. If you rely on memory, you will under-count routine days and over-count visible flares. Photographs taken under the same lighting at the start and at 8, 12 and 24 weeks are far more useful than impressions. If you log skin or hair concerns alongside sleep, mood and stress in the WatchMyHealth wellbeing journal, you can also see whether changes line up with the device or with other lifestyle shifts you have made at the same time.

Do not abandon proven treatments. Photobiomodulation is, at best, a small adjunct on top of basics: sunscreen and retinoids for skin ageing, minoxidil and finasteride for hair loss, dermatologist-guided routines for acne, exercise and standard analgesia for joint pain, evidence-based therapy and medication for depression. If a device's marketing positions it as a replacement for these, that is your cue to walk away.

Watch your mood as well as your skin. If you are using red light at home with the vague hope that it will lift winter blues, pay attention to whether it actually helps — and whether something better-evidenced (morning bright light, exercise, structured therapy) might serve you better. Tracking your daily mood for a few weeks before and after starting any new intervention, in a tool like the WatchMyHealth mood log, makes it much harder to fool yourself with placebo enthusiasm.

The bottom line

Red light therapy is not magic, and it is not snake oil. It is a real research area with a few well-supported clinical applications — supportive oncology care, modest skin rejuvenation, hair regrowth in patterned hair loss, and pain reduction in some musculoskeletal conditions — surrounded by a much larger penumbra of marketing claims the evidence does not support.

The realistic framing: photobiomodulation is a mild, biologically plausible intervention that, used at the right wavelengths and doses, can move some clinical outcomes a small amount. It is not a substitute for sleep, sunscreen, exercise, validated medications or evidence-based mental-health care. Used as an add-on to a science-based routine, an FDA-cleared LED mask or laser cap can be reasonable. Used as the missing key to energy, mood, fat loss and ageless skin, it will mostly just lighten your wallet.